AI assistant
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2017
Feb 22, 2017
32782_dirs_2017-02-22_fe3bdb1e-4c17-4a17-af43-bc34a6341c94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2017-02-17
Reporting Person: HENNEY CHRISTOPHER S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-17 | Ordinary Shares, par value $0.01 per share | M | 4011 | $6.65 | Acquired | 4011 | Direct |
| 2017-02-17 | Ordinary Shares, par value $0.01 per share | S | 4011 | $57.0632 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-17 | Stock Option (right to buy) | $6.65 | M | 4011 | Disposed | 2023-03-18 | Ordinary Shares (4011) | Direct |
Footnotes
F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
F2: The transaction was executed in multiple trades in prices ranging from $57.00 to $57.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
F3: The shares subject to the option are fully vested and exercisable as of the date hereof.